| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $390K | — | — |
| R&D Expense | $1.3M | +26.1% | -59.4% |
| SG&A Expense | $6.5M | +55.1% | +264.7% |
| Operating Income | -$7.7M | -39.8% | -58.2% |
| Pre-tax Income | -$8.8M | -37.2% | -48.5% |
| Income Tax | $132K | +123.7% | -2.9% |
| Net Income | -$9.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.0M | -15.5% | -17.9% |
| Accounts Receivable | $448K | — | — |
| Inventory | $1.1M | +21.2% | — |
| Current Assets | $13.7M | -7.8% | -13.4% |
| Total Assets | $32.5M | -4.4% | +104.1% |
| Current Liabilities | $6.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.3M | — | — |
| Capital Expenditures | $14K | — | — |
| Investing Cash Flow | -$14K | — | — |
| Financing Cash Flow | $2.2M | — | — |
| Free Cash Flow | -$15.3M | — | — |
| -47.3% |
| EPS (Basic) | -$0.20 | -25.0% | +33.3% |
| EPS (Diluted) | -$0.20 | -25.0% | +33.3% |
| +16.2% |
| -65.6% |
| Long-term Debt | $20.0M | -0.3% | +78.6% |
| Total Liabilities | $39.9M | +5.2% | +45.4% |
| Stockholders' Equity | -$7.4M | -89.9% | +35.9% |